Mutant mice treated with the NLRP3-inhibitor MCC950, show normal EF and fractional shortening, develop no arrhythmias and show no cardiac fibrosis unlike vehicle-treated littermates [59]. The gene discussed is NLRP3; the disease is cardiac arrhythmia.